MoneyWorks4Me

Natco Pharma informs about press release

02 Sep 2021 Evaluate

Natco Pharma has informed that it enclosed a press release on 2nd September 2021 titled ‘Natco Pharma (Canada) Inc. announces the launch of PrNAT-LENALIDOMIDE Capsules, the first generic alternative to Revlimid®’ under Regulation 30 of SEBI (LODR) Regulations 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..